Cargando…
Inhibition of stromal CXCR4 impairs development of lung metastases
Compelling evidence has emerged in recent years indicating that stromal cells play a critical role in disease progression. CXCR4 is a G-protein-coupled receptor with a major role in lymphocyte homing. Its ligand, CXCL12, is a highly efficient chemotactic factor for T cells, monocytes, pre-B cells, d...
Autores principales: | D’Alterio, Crescenzo, Barbieri, Antonio, Portella, Luigi, Palma, Giuseppe, Polimeno, Marianeve, Riccio, Anna, Ieranò, Caterina, Franco, Renato, Scognamiglio, Giosuè, Bryce, Jane, Luciano, Antonio, Rea, Domenica, Arra, Claudio, Scala, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448054/ https://www.ncbi.nlm.nih.gov/pubmed/22399057 http://dx.doi.org/10.1007/s00262-012-1223-7 |
Ejemplares similares
-
Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
por: Portella, Luigi, et al.
Publicado: (2013) -
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
por: Neve Polimeno, Maria, et al.
Publicado: (2015) -
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
por: D’Alterio, Crescenzo, et al.
Publicado: (2019) -
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells
por: Ieranò, Caterina, et al.
Publicado: (2019) -
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)